Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is curative gastrectomy justified for gastric cancer with cytology positive as the only stage IV factor?
Authors
Keywords
-
Journal
LANGENBECKS ARCHIVES OF SURGERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-09
DOI
10.1007/s00423-019-01791-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
- (2018) Keiji Nishibeppu et al. BMC CANCER
- The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy
- (2017) Kazuki Kano et al. International Journal of Clinical Oncology
- Japanese gastric cancer treatment guidelines 2014 (ver. 4)
- (2016) Gastric Cancer
- Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer
- (2016) Shuhei Komatsu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
- (2014) A. Tsuburaya et al. BRITISH JOURNAL OF SURGERY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)
- (2013) Yoshiaki Iwasaki et al. JOURNAL OF SURGICAL ONCOLOGY
- Differences in risk factors between patterns of recurrence in patients after curative resection for advanced gastric carcinoma
- (2013) Yoshitsugu Nakanishi et al. World Journal of Surgical Oncology
- Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study
- (2012) Yasuhiro Kodera et al. Gastric Cancer
- Borrmann’s Macroscopic Criteria and p-Smad2 Expression Are Useful Predictive Prognostic Markers for Cytology-Positive Gastric Cancer Patients Without Overt Peritoneal Metastasis
- (2011) Satoru Noda et al. ANNALS OF SURGICAL ONCOLOGY
- A systematic review of surgery for non-curative gastric cancer
- (2011) Alyson L. Mahar et al. Gastric Cancer
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology
- (2011) Cheong Ah Oh et al. JOURNAL OF SURGICAL ONCOLOGY
- Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer
- (2010) M. Degiuli et al. BRITISH JOURNAL OF SURGERY
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
- (2010) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
- (2010) Ilfet Songun et al. LANCET ONCOLOGY
- Gastric cancer
- (2009) Henk H Hartgrink et al. LANCET
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started